Norrington
TL3 Regular · Klaipėda, LT
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 6 December 2024 · last posted 2d · groups: journal-club
141 posts, newest first. Showing up to 150.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #81 · Outcomes › Progress reports · 26 Jul 2026 · 1 like Post #79 and I disagree about the size of the effect, not about the direction. A single scale used throughout beats a more accurate scale introduced halfway through.…
-
Why the Start Here categories exist, and what they are not for Replied, post #37 · Start Here › Welcome · 25 Jul 2026 · 2 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #48 · Clinical › Prescriber conversations · 25 Jul 2026 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #22 · Analytics › Impurities & related substances · 24 Jul 2026 · 2 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
-
Request: a per-category review queue Replied, post #127 · Meta › Feature requests · 24 Jul 2026 · 0 likes Post #126 answers the question as asked. The question underneath it is different. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
Which categories are strict and which are relaxed, honestly Replied, post #28 · Start Here › Welcome · 19 Jul 2026 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
-
Pooling trials with different estimands Replied, post #105 · Evidence › Meta-analyses · 17 Jul 2026 · 4 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Tracking intake honestly when appetite is absent Replied, post #102 · Nutrition & Training › Protein & intake · 17 Jul 2026 · 9 likes Narrowing post #99, because the general version has more than one answer. Fibre and fluid tend to fall alongside protein when intake drops, and the constipation…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #104 · Compounds › Semaglutide · 14 Jul 2026 · 6 likes Reading rather than answering, but this is the post I would point somebody at.
-
Which categories are strict and which are relaxed, honestly Replied, post #11 · Start Here › Welcome · 13 Jul 2026 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #8 · Sourcing › Regulatory · 10 Jul 2026 · 5 likes Post #5 is right about the mechanism and I think understates the practical bit. Generic or biosimilar entry depends on patent and exclusivity positions that are…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #34 · Pharmacology › Receptor biology · 3 Jul 2026 · 14 likes Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis for expecting an amylin analogue and an incretin agonist to add…
-
How shortages have affected compounding permissions Replied, post #8 · Access › Shortages · 1 Jul 2026 · 0 likes Posting my shortages numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #48 · Evidence › Journal club · 23 Jun 2026 · 9 likes Post #44 describes the usual case. This is about the unusual one. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #87 · Sourcing › Vendor reports · 20 Jun 2026 · 23 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. I have kept the units in…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #59 · Analytics › Home & field testing · 18 Jun 2026 · 5 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. That…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #58 · Wellbeing › Sleep · 13 Jun 2026 · 0 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #27 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 1 like Nothing to add, except that this is the answer I would give if asked.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #77 · Practice › Administration · 12 Jun 2026 · 18 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
What a good consultation looks like from the other side Replied, post #48 · Clinical › Prescriber conversations · 9 Jun 2026 · 0 likes Answering the question post #46 raises rather than the one it answers. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
-
How to ask a question when you cannot say why you are asking it Replied, post #3 · marked as the solution · Start Here › How to Ask · 30 May 2026 · 31 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #7 · Compounds › Semaglutide · 23 May 2026 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Follow-up: Sleep quality changes during weight loss Replied, post #26 · Wellbeing › Sleep · 20 May 2026 · 21 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
-
Naming conventions for research peptides and the confusion they cause Replied, post #4 · Compounds › Other compounds · 16 May 2026 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #22 · Compounds › Retatrutide · 10 May 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #117 · Compounds › Tirzepatide · 9 May 2026 · 24 likes Post #113 and I disagree about the size of the effect, not about the direction. I changed my mind about 2.5 mg starting dose after someone here asked me for the source…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #96 · Devices › Syringes & needles · 7 May 2026 · 0 likes Taking post #95 at face value and following it one step further. Two people in this thread mean different things by 0.3 ml versus 0.5 ml and are disagreeing about the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #30 · Compounds › Secretagogues & GH axis · 9 Apr 2026 · 9 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #13 · Analytics › COA interpretation · 4 Apr 2026 · 7 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. An itemised related-substances table with retention times says…
-
Follow-up: State-level differences that actually matter Replied, post #2 · Regional › North America · 3 Apr 2026 · 4 likes If you are new and reading this thread for the answer to State-level differences: the answer is conditional, the conditions are in the third reply, and the rest of the…
-
Amylin receptor signalling and satiety — what changed since Replied, post #52 · Pharmacology › Receptor biology · 28 Mar 2026 · 26 likes Post #49 is the version of this I will quote in future. One addition. Receptor occupancy required for a clinical effect is not the same as full occupancy, and…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #21 · Sourcing › Red flags · 25 Mar 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. Reading this supplier thread as someone who came in with a fixed view: the third and seventh…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #33 · Practice › Administration · 15 Mar 2026 · 6 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #9 · Practice › Reconstitution · 14 Mar 2026 · 2 likes Understood, and I withdraw the assumption I opened with.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #65 · Lounge › Introductions · 14 Mar 2026 · 10 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Revisiting: Absolute versus relative contraindications Replied, post #42 · Safety › Contraindications · 12 Mar 2026 · 1 like Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #44 · Analytics › Impurities & related substances · 25 Feb 2026 · 1 like The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the intended species, under one integration convention, on one…
-
Five questions in one post gets you one answer — how to split them Replied, post #15 · Start Here › How to Ask · 18 Feb 2026 · 0 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.
-
Trifluoroacetate content and its consequences Replied, post #123 · Analytics › Impurities & related substances · 10 Feb 2026 · 0 likes Trifluoroacetate content: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #29 · Research Methods › Statistics · 10 Feb 2026 · 0 likes Least significant change is the concept that makes measurement precision usable. Below it, a difference between two readings is not distinguishable from noise. If it…
-
Coverage in the US: a map of the usual obstacles Replied, post #37 · Regional › North America · 16 Jan 2026 · 4 likes Building on post #34 rather than restating it. United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are…
-
The most useful thing you learned here that was not the answer you came for Replied, post #14 · Lounge › Off topic · 14 Jan 2026 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. On reflection I would soften that slightly.
-
Early satiety becoming a problem rather than a benefit Replied, post #24 · Practice › Side effects · 11 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #55 · Pharmacology › Pharmacokinetics · 8 Jan 2026 · 15 likes A note on how Half-life gets discussed rather than on Half-life itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #123 · Documentation › Doc review · 31 Dec 2025 · 3 likes I read post #121 twice before replying, because I had assumed the opposite. Second maintainers matter. A single maintainer is a single point of failure and every…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #28 · Compounds › Tirzepatide · 8 Dec 2025 · 2 likes Post #27 is the version of this I will quote in future. One addition. Reading SURMOUNT-1 without the press would be much easier to settle if anyone reported the…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #11 · Start Here › Welcome · 7 Dec 2025 · 13 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #34 · Compounds › Tirzepatide · 5 Dec 2025 · 12 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Documentation that appears only after payment Replied, post #96 · Sourcing › Red flags · 4 Dec 2025 · 8 likes Documentation sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Heterogeneity as information rather than as a nuisance Replied, post #12 · Evidence › Meta-analyses · 30 Nov 2025 · 21 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #8 · Meta › Site feedback · 26 Nov 2025 · 13 likes Confirming post #6 from a second method, which matters more than confirming it from a second person. Suggestion rather than complaint: the vendor pages carry a review…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #51 · Analytics › Impurities & related substances · 24 Nov 2025 · 19 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Heterogeneity as information rather than as a nuisance Replied, post #4 · Evidence › Meta-analyses · 20 Nov 2025 · 0 likes Worth separating two things that post #2 runs together. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #15 · Analytics › Impurities & related substances · 16 Nov 2025 · 7 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
[2026 update] What steady state means for the decision to escalate Replied, post #52 · Practice › Dosing & titration · 10 Nov 2025 · 0 likes What would change my mind on steady state is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #24 · Data & Tools › Calculators · 6 Nov 2025 · 26 likes The residual-volume question belongs in the tool rather than in a footnote, because it is the difference between the calculation and reality. The literature is thinner…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #45 · Practice › Interactions · 6 Nov 2025 · 1 like A note on how Warfarin and altered intake gets discussed rather than on Warfarin and altered intake itself: the confident posts get the replies and the careful ones get…
-
Prescription requirements and telehealth models Replied, post #2 · Sourcing › Regulatory · 4 Nov 2025 · 0 likes Narrowing the opening post, because the general version has more than one answer. Trying to state the prescription requirements and telehealth models position in a way…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #18 · Analytics › Impurities & related substances · 1 Nov 2025 · 4 likes Distinguishing three things in the particulates discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Revisiting: Gallbladder disease risk with rapid weight loss Replied, post #3 · Clinical › Comorbidities · 31 Oct 2025 · 6 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Sleep quality changes during weight loss — what changed since Replied, post #41 · Wellbeing › Sleep · 27 Oct 2025 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Personal import allowances, compared — a second dataset Replied, post #14 · Access › International · 26 Oct 2025 · 3 likes Worth separating two things that post #10 runs together. Reporting rather than recommending, on Personal import allowances. What happened is above. Whether it should…
-
Follow-up: What a seizure notice actually says Replied, post #10 · Sourcing › Logistics · 24 Oct 2025 · 4 likes Post #6 put the caveat in the right place and I want to underline it. Seizure notice would be much easier to settle if anyone reported the denominator. Almost nobody…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #8 · Analytics › Method validation · 20 Oct 2025 · 31 likes Narrowing post #7, because the general version has more than one answer. I read the earlier replies on inter-laboratory comparison twice before writing this, because I…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #15 · Compounds › Tirzepatide · 17 Oct 2025 · 12 likes I would put moderate confidence on the mainstream reading of Reading SURMOUNT-1 without the press and no more. That is not scepticism for its own sake; it is where the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #84 · Practice › Storage & stability · 14 Oct 2025 · 6 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #89 · Lounge › Off topic · 11 Oct 2025 · 33 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Sleep quality changes during weight loss — what changed since Replied, post #16 · Wellbeing › Sleep · 4 Oct 2025 · 1 like Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #39 · Analytics › Mass spectrometry · 25 Sep 2025 · 0 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #36 · Compounds › Oral incretins · 25 Sep 2025 · 11 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #70 · Practice › Side effects · 17 Sep 2025 · 4 likes The arithmetic in post #67 is right; the assumption feeding it is the part to check. Counterpoint on nausea timeline, offered without confidence: the same observation…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #7 · Practice › Side effects · 7 Sep 2025 · 25 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #127 · Practice › Storage & stability · 30 Aug 2025 · 2 likes Filing a mild objection to the consensus on published stability data actually covers. Mild because I might be wrong; an objection because nobody has addressed the case…
-
Hypertension improvement and when medication needs revisiting Replied, post #29 · Clinical › Comorbidities · 28 Aug 2025 · 24 likes Offering a way to settle hypertension improvement rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #4 · Lounge › Off topic · 23 Aug 2025 · 0 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does. I would be…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #65 · Clinical › Special populations · 22 Aug 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #30 · Evidence › Preprints · 20 Aug 2025 · 0 likes Picking up post #28: that is the part I would want checked first. Media coverage of preprints rarely mentions the status. That is where most of the downstream confusion…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #116 · Practice › Storage & stability · 18 Aug 2025 · 10 likes Adding the measurement that post #115 says would settle it. Something worth flagging about published stability data actually covers: the strongest-sounding claims in…
-
A request that was declined, and the reasoning — a second dataset Replied, post #78 · Documentation › Wiki requests · 13 Aug 2025 · 1 like The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. Where I would look next, rather than where…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #105 · Wellbeing › Mental health · 6 Aug 2025 · 0 likes Post #103 describes the usual case. This is about the unusual one. If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer…
-
Tracking that stops updating and then resumes — the long version Replied, post #2 · Sourcing › Logistics · 31 Jul 2025 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #84 · Outcomes › Progress reports · 23 Jul 2025 · 25 likes Where I part company with post #82, and it is a narrow parting. What I want from this 18-month record thread is the list of things that would need to be true for the…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #77 · Clinical › Comorbidities · 23 Jul 2025 · 0 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. What I would check first on Cardiovascular risk is whether the thing being measured…
-
Sequence verification for an obscure compound: how it is done Replied, post #100 · Compounds › Other compounds · 21 Jul 2025 · 1 like Where I part company with post #96, and it is a narrow parting. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
-
Thyroid function tests during substantial weight change Replied, post #3 · Clinical › Bloodwork · 9 Jul 2025 · 12 likes Thyroid function tests during substantial is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #130 · Compounds › Tirzepatide · 7 Jul 2025 · 1 like Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Counter-ion content and its effect on measured mass Replied, post #77 · Analytics › Mass spectrometry · 28 Jun 2025 · 0 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.
-
Sodium, potassium and magnesium when intake drops Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 23 Jun 2025 · 17 likes Post #24 is right about the mechanism and I think understates the practical bit. Exercise and electrolyte losses: sweating during exercise increases sodium and…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #47 · Access › Insurance & coverage · 10 Jun 2025 · 5 likes Building on post #44 rather than restating it. I would put moderate confidence on the mainstream reading of appeal and no more. That is not scepticism for its own sake;…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #22 · Evidence › Trials · 9 Jun 2025 · 30 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #10 · Start Here › How to Ask · 6 Jun 2025 · 3 likes Useful. I have added it to my own notes with the date on it.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #60 · Compounds › Other compounds · 30 May 2025 · 15 likes I read post #56 twice before replying, because I had assumed the opposite. Anything in this subcategory with a published trial behind it should be discussed separately…
-
Sequence verification for an obscure compound: how it is done Replied, post #45 · Compounds › Other compounds · 26 May 2025 · 22 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reverting an edit that had no revision note Replied, post #5 · Meta › Wiki maintenance · 19 May 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Water content on a certificate and why it changes the arithmetic Replied, post #22 · Analytics › COA interpretation · 15 May 2025 · 24 likes Post #19 is the version of this I will quote in future. One addition. The bit of water content that nobody enjoys is that the answer changes depending on what you are…
-
Lean mass preservation: what the evidence supports Replied, post #17 · Outcomes › Body composition · 15 May 2025 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. On lean mass preservation the community has more anecdote than the confidence in this…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #26 · Evidence › Journal club · 4 May 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Counter-ion content and its effect on measured mass Replied, post #28 · Analytics › Mass spectrometry · 30 Apr 2025 · 18 likes Coming back to post #26, because the follow-up matters more than the original answer. For anyone finding this later: the short answer on counter-ion content is that it…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #90 · Devices › Cold chain · 23 Apr 2025 · 12 likes The practical question after a warm arrival is what to do, and there is no test at home that answers it. Independent testing is the only route to an actual answer. I am…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #125 · Evidence › Journal club · 23 Apr 2025 · 3 likes Coming back to post #121, because the follow-up matters more than the original answer. On STEP 1: the maintained page in the documentation commons covers the general…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #118 · Evidence › Journal club · 22 Apr 2025 · 0 likes Coming back to post #116, because the follow-up matters more than the original answer. The practical version of STEP 1 is three sentences long. The rigorous version is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #78 · Practice › Reconstitution · 13 Apr 2025 · 14 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
The C-cell question: rodent findings and their human context Replied, post #7 · Compounds › Semaglutide · 12 Apr 2025 · 8 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #27 · Evidence › Trials · 6 Apr 2025 · 0 likes Where the Open-label extensions reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #83 · Sourcing › Vendor reports · 17 Mar 2025 · 32 likes I had written a reply contradicting post #81 and deleted it. Here is what survived. One lot is one lot. It becomes a pattern at three or four, and the record is built…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #68 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Adding the measurement that post #67 says would settle it. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure…
-
Validating a method you did not develop — does this still hold? Replied, post #122 · Analytics › Method validation · 16 Mar 2025 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
When "no data" is the complete and final answer Replied, post #114 · Compounds › Other compounds · 10 Mar 2025 · 32 likes Nicotinamide adenine dinucleotide preparations are not peptides at all and the certificate conventions are completely different. Reading one as though it were a peptide…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #81 · Analytics › Mass spectrometry · 8 Mar 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #6 · Practice › Interactions · 3 Mar 2025 · 28 likes Coming back to post #4, because the follow-up matters more than the original answer. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #46 · Sourcing › Regulatory · 1 Mar 2025 · 1 like Narrowing post #44, because the general version has more than one answer. Primary documents matter: regulatory positions are published in official documents. Reading…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #17 · Compounds › Secretagogues & GH axis · 28 Feb 2025 · 15 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Distinguishing a deletion sequence by mass alone Replied, post #107 · Analytics › Mass spectrometry · 19 Feb 2025 · 9 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Scheduled maintenance and what will be unavailable Replied, post #47 · Meta › Announcements · 18 Feb 2025 · 1 like Small correction to my own earlier position on scheduled maintenance. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #46 · Pharmacology › Receptor biology · 8 Feb 2025 · 8 likes Confirming post #45 from a second method, which matters more than confirming it from a second person. Biased agonism — where different ligands at the same receptor…
-
Consistent declarations and why they matter more than clever ones Replied, post #6 · Sourcing › Logistics · 7 Feb 2025 · 10 likes Fair, and the limits you put on it are the part I will remember.
-
Distinguishing a deletion sequence by mass alone Replied, post #30 · Analytics › Mass spectrometry · 29 Jan 2025 · 3 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Resolution and mass accuracy are different specifications. An…
-
Scheduled maintenance and what will be unavailable Replied, post #18 · Meta › Announcements · 18 Jan 2025 · 14 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. Written from notes rather than memory, which is why…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #13 · Data & Tools › Calculators · 14 Jan 2025 · 22 likes If a tool asks for a value you do not have, the honest response is to find the value rather than to estimate it. Estimated inputs propagate silently.
-
Recovery when intake is low: what to cut first Replied, post #52 · Nutrition & Training › Resistance training · 12 Jan 2025 · 3 likes Posting my recovery numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
-
A promotion I argued against, and why I lost Replied, post #51 · Documentation › Doc review · 5 Jan 2025 · 0 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on.
-
Oxidation pathways for methionine and tryptophan Replied, post #61 · Analytics › Impurities & related substances · 31 Dec 2024 · 1 like The bit of oxidation pathways for methionine that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
-
Oxidation pathways for methionine and tryptophan Replied, post #36 · Analytics › Impurities & related substances · 28 Dec 2024 · 2 likes Picking up post #34: that is the part I would want checked first. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
Body image changing more slowly than the body Replied, post #56 · Wellbeing › Mental health · 17 Dec 2024 · 31 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Replied, post #5 · Practice › Dosing & titration · 3 Dec 2024 · 8 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #51 · Access › Insurance & coverage · 2 Dec 2024 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Washout with a one-week half-life: the arithmetic Replied, post #51 · Research Methods › N-of-1 designs · 2 Dec 2024 · 0 likes Adding the measurement that post #48 says would settle it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective…
-
One lot is one lot: when a report becomes a pattern Started this topic · Sourcing › Vendor reports · 15 Nov 2024 · 8 likes Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #80 · Clinical › Prescriber conversations · 18 Oct 2024 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Requesting a page: what makes a good request — what changed since Replied, post #19 · Documentation › Wiki requests · 9 Oct 2024 · 2 likes Answering the question post #18 raises rather than the one it answers. A document with no maintainer becomes wrong quietly, which is worse than not existing, because it…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #21 · Clinical › Comorbidities · 5 Oct 2024 · 2 likes Post #17 put the caveat in the right place and I want to underline it. I would put moderate confidence on the mainstream reading of Type 2 diabetes and no more. That is…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Started this topic · Clinical › Comorbidities · 23 Sep 2024 · 42 likes Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is…
-
Why a preprint's supplementary material is often the best part Replied, post #25 · Evidence › Preprints · 15 Sep 2024 · 1 like A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. That is the version I…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Started this topic · Compounds › Other compounds · 11 Sep 2024 · 0 likes Posting this under the heading it deserves: Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Everything below is what sits behind that.…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #2 · Clinical › Bloodwork · 7 Sep 2024 · 26 likes Narrowing the opening post, because the general version has more than one answer. The confident answers on Micronutrient status and the well-sourced answers are not the…
-
Transit times by route, from a logged dataset — the long version Replied, post #9 · Sourcing › Logistics · 1 Sep 2024 · 1 like A tracking gap at a customs facility is the most common cause of an unexpectedly long transit and the segment nobody has visibility of. Scoping that to what I have…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #2 · Analytics › Home & field testing · 26 Aug 2024 · 30 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Correlation in a self-tracked dataset: what it can support Replied, post #5 · Research Methods › Statistics · 20 Aug 2024 · 3 likes Post #3 describes the usual case. This is about the unusual one. Adding a small correction to the correlation summary above rather than a disagreement with it. The…
-
How to ask for a dose change without antagonising anyone Started this topic · Clinical › Prescriber conversations · 23 Jun 2024 · 6 likes The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. A question about…
-
How this community labels and discusses unrefereed work Replied, post #8 · Evidence › Preprints · 7 Jun 2024 · 11 likes Worth separating two things that post #5 runs together. On community labels I would separate what is worth knowing from what is worth acting on. The first list is long…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #2 · Practice › Dosing & titration · 17 May 2024 · 19 likes Reading this four-week escalation interval thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.